Research and development expenditure
First written in FY2017-Q1. 16 of 34 entries say "Advanced", first in FY2017. Latest entry: FY2026.
Shima Seiki Mfg. moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Softened".
- FY2026SoftenedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,262 million.」
R&D expenses decreased, changing from ¥3,752 million in the previous fiscal year to ¥3,262 million, while R&D activities continued. - FY2026-H1SoftenedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥1,474 million.」
R&D expenses decreased, changing from ¥1,746 million in the same period of the previous year to ¥1,474 million, while R&D activities continued. - FY2025AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,752 million.」
R&D expenses increased, changing from ¥3,340 million in the previous fiscal year to ¥3,752 million. - FY2025-H1AdvancedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥1,746 million.」
R&D expenses of ¥1,746 million were recorded for the current interim consolidated accounting period, while R&D activities continued. - FY2024SoftenedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,340 million.」
R&D expenses decreased, changing from ¥3,893 million in the previous fiscal year to ¥3,340 million, while R&D activities continued. - FY2024-Q3SoftenedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,259 million.」
R&D expenses decreased, changing from ¥2,836 million in the cumulative same period of the previous year to ¥2,259 million, while R&D activities continued. - FY2024-Q2SoftenedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,604 million.」
R&D expenses decreased, changing from ¥1,816 million in the cumulative same period of the previous year to ¥1,604 million, while R&D activities continued. - FY2024-Q1SoftenedAnnual report
「The total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥739 million.」
R&D expenses decreased, changing from ¥830 million in the same period of the previous year to ¥739 million, while R&D activities continued. - FY2023AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,893 million.」
R&D expenses increased, changing from ¥2,836 million in the previous fiscal year to ¥3,893 million, and the scale of R&D activities expanded. - FY2023-Q3AdvancedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,836 million.」
R&D expenses increased, changing from ¥2,487 million in the cumulative same period of the previous year to ¥2,836 million. - FY2023-Q2AdvancedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,816 million.」
R&D expenses increased, changing from ¥1,580 million in the cumulative same period of the previous year to ¥1,816 million, while R&D activities continued. - FY2023-Q1AdvancedAnnual report
「The total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥911 million.」
R&D expenses increased, changing from ¥765 million in the same period of the previous year to ¥911 million, while R&D activities continued. - FY2022-Q3AdvancedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,487 million.」
R&D expenses increased, changing from ¥2,397 million in the cumulative same period of the previous year to ¥2,487 million. - FY2022-Q2AdvancedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,674 million.」
R&D expenses increased, changing from ¥1,580 million in the cumulative same period of the previous year to ¥1,674 million. - FY2022-Q1AdvancedAnnual report
「The total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥830 million.」
R&D expenses increased, changing from ¥765 million in the same period of the previous year to ¥830 million, while R&D activities continued. - FY2021AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,310 million.」
R&D expenses increased, changing from ¥3,250 million in the previous fiscal year to ¥3,310 million, while R&D activities continued. - FY2021-Q3SoftenedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,397 million.」
R&D expenses decreased, changing from ¥2,530 million in the cumulative same period of the previous year to ¥2,397 million, while R&D activities continued. - FY2021-Q2SoftenedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,580 million.」
R&D expenses decreased, changing from ¥1,794 million in the cumulative same period of the previous year to ¥1,580 million, while R&D activities continued. - FY2021-Q1SoftenedAnnual report
「The total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥765 million.」
R&D expenses decreased, changing from ¥878 million in the same quarter of the previous year to ¥765 million, while R&D activities continued. - FY2020-Q3AdvancedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,530 million.」
R&D expenses changed from ¥2,400 million in the cumulative same period of the previous year to ¥2,530 million. - FY2020-Q2AdvancedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,794 million.」
R&D expenses changed from ¥1,545 million in the cumulative same period of the previous year to ¥1,794 million. - FY2020-Q1AdvancedAnnual report
「The total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥878 million.」
R&D expenses changed from ¥760 million in the same quarter of the previous year to ¥878 million. - FY2019AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,250 million.」
R&D expenses changed from ¥2,794 million in the previous fiscal year to ¥3,250 million, indicating an expansion in the scale of R&D activities on a full-year basis. - FY2019-Q3RestatedAnnual report
「The total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,400 million.」
R&D activities and R&D spending continued, with ¥2,400 million recorded for the cumulative third quarter. - FY2019-Q2RestatedAnnual report
「The total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,545 million.」
R&D activities and R&D spending continued, with ¥1,545 million recorded for the cumulative second quarter. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥760 million.」
Research and development activities and related expenditure continued, with ¥760 million recognized on a cumulative basis for the first quarter. - FY2018AdvancedAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥2,794 million.」
Research and development expenses increased from ¥2,676 million in the previous fiscal year to ¥2,794 million, and specific progress in product development was also reported. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the first nine months of the current consolidated fiscal year were ¥2,149 million.」
Research and development activities and related expenditure continued, with ¥2,149 million recognized on a cumulative basis for the first nine months. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the first half of the current consolidated fiscal year were ¥1,427 million.」
Research and development activities and related expenditure continued, with ¥1,427 million recognized on a cumulative basis for the first half. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥701 million.」
Research and development activities and related expenditure continued, with ¥701 million recognized on a cumulative basis for the first quarter. - FY2017AdvancedAnnual report
「Our corporate group conducts a broad range of research and development activities, and total research and development expenses for the current consolidated fiscal year were ¥2,676 million.」
Research and development expenses totaled ¥2,676 million for the full year on a cumulative basis, indicating continued research and development activities and the full-year results. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the first nine months of the current consolidated fiscal year were ¥2,002 million.」
Research and development expenditure continued, with ¥2,002 million recognized on a cumulative basis for the first nine months. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the first half of the current consolidated fiscal year were ¥1,311 million.」
Research and development expenses continued to be recognized, reaching ¥1,311 million on a cumulative basis. - FY2017-Q1First statedAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥645 million.」
The total R&D expenses for the quarter are stated.